Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes.
Potent broad-spectrum antiviral agents are urgently needed to combat existing and emerging viral infections. This is particularly important considering that vaccine development is a costly and time consuming process and that viruses constantly mutate and render the vaccine ineffective. Antimicrobial...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0278419 |
| _version_ | 1828069166082424832 |
|---|---|
| author | Abubakr A M Omer Jorma Hinkula Pham-Tue-Hung Tran Wessam Melik Elisa Zattarin Daniel Aili Robert Selegård Torbjörn Bengtsson Hazem Khalaf |
| author_facet | Abubakr A M Omer Jorma Hinkula Pham-Tue-Hung Tran Wessam Melik Elisa Zattarin Daniel Aili Robert Selegård Torbjörn Bengtsson Hazem Khalaf |
| author_sort | Abubakr A M Omer |
| collection | DOAJ |
| description | Potent broad-spectrum antiviral agents are urgently needed to combat existing and emerging viral infections. This is particularly important considering that vaccine development is a costly and time consuming process and that viruses constantly mutate and render the vaccine ineffective. Antimicrobial peptides (AMP), such as bacteriocins, are attractive candidates as antiviral agents against enveloped viruses. One of these bacteriocins is PLNC8 αβ, which consists of amphipathic peptides with positive net charges that display high affinity for negatively charged pathogen membrane structures, including phosphatidylserine rich lipid membranes of viral envelopes. Due to the morphological and physiological differences between viral envelopes and host cell plasma membranes, PLNC8 αβ is thought to have high safety profile by specifically targeting viral envelopes without effecting host cell membranes. In this study, we have tested the antiviral effects of PLNC8 αβ against the flaviviruses Langat and Kunjin, coronavirus SARS-CoV-2, influenza A virus (IAV), and human immunodeficiency virus-1 (HIV-1). The concentration of PLNC8 αβ that is required to eliminate all the infective virus particles is in the range of nanomolar (nM) to micromolar (μM), which is surprisingly efficient considering the high content of cholesterol (8-35%) in their lipid envelopes. We found that viruses replicating in the endoplasmic reticulum (ER)/Golgi complex, e.g. SARS-CoV-2 and flaviviruses, are considerably more susceptible to PLNC8 αβ, compared to viruses that acquire their lipid envelope from the plasma membrane, such as IAV and HIV-1. Development of novel broad-spectrum antiviral agents can significantly benefit human health by rapidly and efficiently eliminating infectious virions and thereby limit virus dissemination and spreading between individuals. PLNC8 αβ can potentially be developed into an effective and safe antiviral agent that targets the lipid compartments of viral envelopes of extracellular virions, more or less independent of virus antigenic mutations, which faces many antiviral drugs and vaccines. |
| first_indexed | 2024-04-11T00:14:12Z |
| format | Article |
| id | doaj.art-59e870cda5a443ac8a3ad682c3a0133a |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-11T00:14:12Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-59e870cda5a443ac8a3ad682c3a0133a2023-01-09T05:30:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011711e027841910.1371/journal.pone.0278419Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes.Abubakr A M OmerJorma HinkulaPham-Tue-Hung TranWessam MelikElisa ZattarinDaniel AiliRobert SelegårdTorbjörn BengtssonHazem KhalafPotent broad-spectrum antiviral agents are urgently needed to combat existing and emerging viral infections. This is particularly important considering that vaccine development is a costly and time consuming process and that viruses constantly mutate and render the vaccine ineffective. Antimicrobial peptides (AMP), such as bacteriocins, are attractive candidates as antiviral agents against enveloped viruses. One of these bacteriocins is PLNC8 αβ, which consists of amphipathic peptides with positive net charges that display high affinity for negatively charged pathogen membrane structures, including phosphatidylserine rich lipid membranes of viral envelopes. Due to the morphological and physiological differences between viral envelopes and host cell plasma membranes, PLNC8 αβ is thought to have high safety profile by specifically targeting viral envelopes without effecting host cell membranes. In this study, we have tested the antiviral effects of PLNC8 αβ against the flaviviruses Langat and Kunjin, coronavirus SARS-CoV-2, influenza A virus (IAV), and human immunodeficiency virus-1 (HIV-1). The concentration of PLNC8 αβ that is required to eliminate all the infective virus particles is in the range of nanomolar (nM) to micromolar (μM), which is surprisingly efficient considering the high content of cholesterol (8-35%) in their lipid envelopes. We found that viruses replicating in the endoplasmic reticulum (ER)/Golgi complex, e.g. SARS-CoV-2 and flaviviruses, are considerably more susceptible to PLNC8 αβ, compared to viruses that acquire their lipid envelope from the plasma membrane, such as IAV and HIV-1. Development of novel broad-spectrum antiviral agents can significantly benefit human health by rapidly and efficiently eliminating infectious virions and thereby limit virus dissemination and spreading between individuals. PLNC8 αβ can potentially be developed into an effective and safe antiviral agent that targets the lipid compartments of viral envelopes of extracellular virions, more or less independent of virus antigenic mutations, which faces many antiviral drugs and vaccines.https://doi.org/10.1371/journal.pone.0278419 |
| spellingShingle | Abubakr A M Omer Jorma Hinkula Pham-Tue-Hung Tran Wessam Melik Elisa Zattarin Daniel Aili Robert Selegård Torbjörn Bengtsson Hazem Khalaf Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. PLoS ONE |
| title | Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. |
| title_full | Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. |
| title_fullStr | Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. |
| title_full_unstemmed | Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. |
| title_short | Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes. |
| title_sort | plantaricin nc8 αβ rapidly and efficiently inhibits flaviviruses and sars cov 2 by disrupting their envelopes |
| url | https://doi.org/10.1371/journal.pone.0278419 |
| work_keys_str_mv | AT abubakramomer plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT jormahinkula plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT phamtuehungtran plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT wessammelik plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT elisazattarin plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT danielaili plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT robertselegard plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT torbjornbengtsson plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes AT hazemkhalaf plantaricinnc8abrapidlyandefficientlyinhibitsflavivirusesandsarscov2bydisruptingtheirenvelopes |